A randomized study of temozolomide or temozolomide and capecitabine in patients with advanced pancreatic neuroendocrine tumors: Final analysis of efficacy and evaluation of MGMT (ECOG-ACRIN E2211) Meeting Abstract
| Authors: | Kunz, P. L.; Graham, N.; Catalano, P. J.; Nimeiri, H.; Fisher, G. A.; Longacre, T. A.; Suarez, C. J.; Rubin, D.; Yao, J. C.; Kulke, M. H.; Hendifar, A. E.; Shanks, J. C.; Shah, M. H.; Zalupski, M.; Schmulbach, E. L.; Reidy, D. L.; Strosberg, J. R.; Wong, T. Z.; O'Dwyer, P. J.; Benson, A. B. |
| Abstract Title: | A randomized study of temozolomide or temozolomide and capecitabine in patients with advanced pancreatic neuroendocrine tumors: Final analysis of efficacy and evaluation of MGMT (ECOG-ACRIN E2211) |
| Meeting Title: | 2022 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 40 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2022 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2022-06-01 |
| Language: | English |
| ACCESSION: | WOS:000863680301172 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2022.40.16_suppl.4004 |
| Notes: | Meeting Abstract: 4004 -- Meeting also held virtually -- Source: Wos |
